Triple Immune Blend
Comprehensive immune system support formula
This synergistic peptide blend combines three potent immune-modulating compounds to provide comprehensive immune system support. KPV reduces inflammation, Thymosin Alpha-1 enhances immune function and pathogen defense, while LL-37 delivers broad-spectrum antimicrobial protection and wound healing support, creating a complete immune optimization formula.
3-in-1
Peptide Blend
SC/IM
Administration
1-2x
Daily Dosing
4-12
Week Protocols
Blend Components
This comprehensive blend combines three scientifically-validated immune peptides working synergistically to support inflammation control, immune defense, and antimicrobial protection.
Anti-inflammatory component
Primary Benefits
Reduces systemic and gut inflammation through targeted cytokine modulation while supporting intestinal barrier integrity and mucosal tissue repair.
Immune enhancement component
Primary Benefits
Enhances cell-mediated immunity by optimizing T-cell function, improving pathogen recognition, and supporting comprehensive immune system regulation.
Antimicrobial component
Primary Benefits
Provides natural antimicrobial defense against bacteria, viruses, and fungi while promoting tissue repair, wound healing, and immune barrier function.
The Science
This triple immune blend represents a comprehensive approach to immune system optimization by combining three scientifically-validated peptides with complementary mechanisms of action. Each component targets distinct aspects of immune function: inflammation control, adaptive immunity enhancement, and innate antimicrobial defense.
KPV (Lys-Pro-Val) is a naturally occurring tripeptide fragment of alpha-MSH that powerfully modulates inflammatory pathways by inhibiting NF-κB activation, reducing pro-inflammatory cytokine production while supporting gut barrier integrity. Thymosin Alpha-1 is an immune-regulating peptide that enhances T-cell function, improves cell-mediated immunity, and strengthens the body’s ability to recognize and eliminate pathogens. LL-37 is the only human cathelicidin antimicrobial peptide, providing broad-spectrum defense against bacteria, viruses, and fungi while promoting wound healing and tissue repair.
Together, these three peptides create a synergistic immune support formula that addresses inflammation, adaptive immune function, and antimicrobial protection simultaneously. This comprehensive approach makes the blend particularly effective for individuals with chronic inflammatory conditions, recurrent infections, immune dysregulation, autoimmune disorders, gut health concerns, or those seeking enhanced immune resilience and pathogen defense.
Book a Consultation
How It Works
This blend delivers comprehensive immune support through three complementary pathways that work synergistically to optimize immune function, reduce inflammation, and enhance pathogen defense.
KPV inhibits NF-κB signaling to suppress pro-inflammatory cytokine production while supporting gut barrier function, reducing systemic inflammation and promoting mucosal healing.
Thymosin Alpha-1 optimizes T-cell differentiation and function, enhances dendritic cell maturation, and improves immune surveillance for superior pathogen recognition and elimination.
LL-37 provides broad-spectrum antimicrobial action against bacteria, viruses, and fungi through membrane disruption while promoting wound healing and supporting immune barrier integrity.
Clinical Benefits
Combines inflammation control, adaptive immunity enhancement, and antimicrobial defense for complete immune system optimization across multiple pathways.
KPV’s targeted NF-κB inhibition reduces chronic inflammation throughout the body while supporting gut health and mucosal tissue integrity.
Thymosin Alpha-1 optimizes T-cell function while LL-37 provides broad-spectrum antimicrobial action against bacteria, viruses, and fungi for superior immune defense.
Balances overactive immune responses in autoimmune conditions by regulating inflammatory pathways and optimizing immune cell function without broad immunosuppression.
Supports intestinal barrier integrity through KPV’s mucosal healing properties and LL-37’s antimicrobial action, promoting a healthy gut microbiome and reducing leaky gut.
LL-37 promotes tissue regeneration and accelerates wound healing while reducing infection risk through antimicrobial protection during the healing process.
Your Journey
Our medical team guides you through comprehensive immune optimization with personalized protocols and ongoing support.
Comprehensive evaluation of immune function, inflammatory markers, infection history, and health optimization goals.
Complete immune panels, inflammatory markers, gut health assessment, and baseline labs to guide personalized protocol design.
Receive personalized triple blend dosing regimen based on your immune profile, inflammatory status, and therapeutic objectives.
Regular monitoring with symptom tracking, immune marker testing, and protocol adjustments for optimal immune system performance.
Safety & Candidacy
Each component of this triple immune blend has been extensively studied and demonstrates excellent safety profiles. Our medical team performs comprehensive evaluations to ensure appropriate candidacy and optimal dosing for your individual immune needs.
3x
Complementary immune pathways targeted for comprehensive protection
25+
Years of combined research validating safety and immune benefits
Questions
This triple blend provides comprehensive immune support through three complementary mechanisms. KPV reduces chronic inflammation by inhibiting NF-κB signaling and supporting gut barrier integrity. Thymosin Alpha-1 enhances adaptive immunity by optimizing T-cell function, improving immune surveillance, and strengthening pathogen recognition. LL-37 delivers broad-spectrum antimicrobial defense against bacteria, viruses, and fungi while promoting tissue repair. Together, these peptides create a synergistic formula that addresses inflammation, immune cell function, and pathogen defense simultaneously.
The KPV/TA1/LL37 blend is particularly effective for chronic inflammatory conditions, recurrent infections, immune dysregulation, autoimmune disorders, inflammatory bowel disease, gut health concerns, viral susceptibility, chronic wound healing issues, and general immune optimization. The combination of anti-inflammatory, immune-enhancing, and antimicrobial properties makes it ideal for individuals seeking comprehensive immune system support. Your BHRC physician will assess whether this blend is appropriate for your specific condition and health goals.
The triple immune blend is administered via subcutaneous or intramuscular injection, typically 1-2 times daily depending on the therapeutic protocol and individual immune needs. The 10/10/5mg formulation provides therapeutic doses of all three components in a single convenient injection. Dosing frequency and duration are personalized based on your immune profile, inflammatory markers, infection susceptibility, and treatment objectives. Most protocols range from 4-12 weeks, with some patients benefiting from ongoing maintenance therapy.
Response timelines vary based on the condition being treated and individual immune status. Many patients report reduced infection frequency and improved inflammatory symptoms within 2-4 weeks of consistent use. Improvements in immune markers, T-cell function, and inflammatory cytokine levels typically appear within 4-6 weeks. For chronic inflammatory conditions and gut health concerns, significant benefits often develop over 8-12 weeks as the peptides work synergistically to restore immune balance, reduce inflammation, and enhance pathogen defense.
The triple immune blend has an excellent safety profile with minimal reported side effects. Occasional mild injection site reactions (redness, tenderness) may occur. Unlike broad immunosuppressants, this blend enhances immune function without overstimulation. However, individuals with active systemic infections, certain autoimmune conditions, or those on immunosuppressive medications should consult with their physician before starting therapy. Comprehensive medical evaluation and baseline testing ensure safe and appropriate use. There are no known significant drug interactions, but full medication disclosure is essential during consultation.
Yes, the KPV/TA1/LL37 blend can be safely combined with other peptide therapies, gut healing protocols, anti-inflammatory interventions, and immune support strategies. Many patients use this blend alongside BPC-157 for enhanced gut healing, with NAD+ for cellular health optimization, or as part of comprehensive wellness programs. The blend is generally compatible with conventional medications and supplements, but your BHRC physician will review all current treatments to design an integrated protocol optimized for your specific immune needs and health objectives.
Peptide blend therapy is typically not covered by insurance as it’s considered preventive and regenerative medicine. BHRC offers transparent pricing and flexible payment options to make this innovative immune support therapy accessible. Many patients find the investment worthwhile given the comprehensive benefits for immune function, inflammation reduction, pathogen defense, and overall wellness. Our team can provide detailed cost information and discuss payment plans during your consultation.
Get Started
Schedule a consultation with our medical team to learn if the KPV/TA1/LL37 triple immune blend is right for your wellness journey.
"*" indicates required fields
Or call us directly: +1 213-325-3373
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The KPV/TA1/LL37 blend is provided for immune support and wellness purposes under physician supervision. Individual results may vary. A consultation with our medical team and baseline laboratory testing are required to determine if this therapy is appropriate for you.
